help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chipman, J. J.
Right arrow Articles by Pak, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chipman, J. J.
Right arrow Articles by Pak, C. Y.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 321-324, Copyright © 1980 by Endocrine Society


ARTICLES

Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption

JJ Chipman, J Zerwekh, M Nicar, J Marks and CY Pak

The mechanism by which GH stimulates intestinal calcium absorption was explored. In this study, seven children with idiopathic GH deficiency were studied before and during GH therapy while they were maintained on the same metabolic diet. After 5-14 months of GH administration, fractional intestinal calcium absorption increased from 0.364 +/- 0.114 to 0.449 +/- 0.159 (P less than 0.01), and serum 1,25-dihydroxyvitamin D decreased from 63.7 +/ 19.3 to 46.7 +/ 17.8 pg/ml (P less than 0.025). Serum immunoreactive parathyroid hormone, urinary cAmp, serum 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D did not change significantly. The data suggest that GH does not directly influence parathyroid hormone or vitamin D metabolism. The possibility that relative intestinal resistance to 1,25-dihydroxyvitamin D exists in patients with GH deficiency is considered.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Ahmad, J. Thomas, A. Clewes, M. T. Hopkins, R. Guzder, H. Ibrahim, B. H. Durham, J. P. Vora, and W. D. Fraser
Effects of Growth Hormone Replacement on Parathyroid Hormone Sensitivity and Bone Mineral Metabolism
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2860 - 2868.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N.K. Arden, P. Major, J.R. Poole, R.W. Keen, S. Vaja, R. Swaminathan, C. Cooper, and T.D. Spector
Size at birth, adult intestinal calcium absorption and 1,25(OH)2 vitamin D
QJM, January 1, 2002; 95(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Fatayerji, E. B. Mawer, and R. Eastell
The Role of Insulin-Like Growth Factor I in Age-Related Changes in Calcium Homeostasis in Men
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4657 - 4662.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Chen and D. N. Kalu
Modulation of Intestinal Estrogen Receptor by Ovariectomy, Estrogen and Growth Hormone
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 328 - 333.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Bianda, Y. Glatz, R. Bouillon, E. R. Froesch, and C. Schmid
Effects of Short-Term Insulin-Like Growth Factor-I (IGF-I) or Growth Hormone (GH) Treatment on Bone Metabolism and on Production of 1,25-Dihydroxycholecalciferol in GH-Deficient Adults
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 81 - 87.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society